136 related articles for article (PubMed ID: 17046006)
1. Identification of an isomer impurity in piperaquine drug substance.
Lindegårdh N; Giorgi F; Galletti B; Di Mattia M; Quaglia M; Carnevale D; White NJ; Mazzanti A; Day NP
J Chromatogr A; 2006 Dec; 1135(2):166-9. PubMed ID: 17046006
[TBL] [Abstract][Full Text] [Related]
2. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
3. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
[TBL] [Abstract][Full Text] [Related]
4. Stability profiling of anti-malarial drug piperaquine phosphate and impurities by HPLC-UV, TOF-MS, ESI-MS and NMR.
Yan F; Liu J; Zeng X; Zhang Y; Hang T
Malar J; 2014 Oct; 13():401. PubMed ID: 25311421
[TBL] [Abstract][Full Text] [Related]
5. Application of GC-EI-MS for the identification and investigation of positional isomer in primaquine, an antimalarial drug.
Dongre VG; Karmuse PP; Nimbalkar MM; Singh D; Kumar A
J Pharm Biomed Anal; 2005 Sep; 39(1-2):111-6. PubMed ID: 15905064
[TBL] [Abstract][Full Text] [Related]
6. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
[TBL] [Abstract][Full Text] [Related]
7. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance.
Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K
J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new impurity in lisinopril.
Shinde V; Trivedi A; Upadhayay PR; Gupta NL; Kanase DG; Chikate R
J Pharm Biomed Anal; 2007 Jan; 43(1):381-6. PubMed ID: 16926080
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
[TBL] [Abstract][Full Text] [Related]
10. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
Li M; Lin M; Rustum A
J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
[TBL] [Abstract][Full Text] [Related]
11. Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay.
Huidobro AL; Rupérez FJ; Barbas C
J Pharm Biomed Anal; 2007 Jun; 44(2):404-13. PubMed ID: 17250986
[TBL] [Abstract][Full Text] [Related]
12. Isolation and identification of a new impurity in lorazepam substance.
Cepanec I; Mikuldas H; Litvić M; Vukusić I
Pharmazie; 2001 Nov; 56(11):857-9. PubMed ID: 11817169
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
[TBL] [Abstract][Full Text] [Related]
14. Characterization of human urinary metabolites of the antimalarial piperaquine.
Tarning J; Bergqvist Y; Day NP; Bergquist J; Arvidsson B; White NJ; Ashton M; Lindegårdh N
Drug Metab Dispos; 2006 Dec; 34(12):2011-9. PubMed ID: 16956956
[TBL] [Abstract][Full Text] [Related]
15. Structural identification and characterization of impurities in moxifloxacin.
Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
[TBL] [Abstract][Full Text] [Related]
16. Substituent effects of the N,N-dimethyl- sulfamoyl group on the 1H and 13C NMR spectra of positional isomers of quinolines.
Maślankiewicz A; Maślankiewicz MJ; Marciniec K
Magn Reson Chem; 2008 Feb; 46(2):182-5. PubMed ID: 18088082
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of new impurity in didanosine.
Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
[TBL] [Abstract][Full Text] [Related]
18. Isolation and structural identification of an impurity in fluconazole bulk drug substance.
Dongre VG; Ghugare PD; Karmuse PP; Soudagar SR; Panda N; Kumar A
J Pharm Biomed Anal; 2007 Nov; 45(3):422-9. PubMed ID: 17706390
[TBL] [Abstract][Full Text] [Related]
19. Impurity profile study of dutasteride.
Satyanarayana K; Srinivas K; Himabindu V; Mahesh Reddy G
Pharmazie; 2007 Oct; 62(10):743-6. PubMed ID: 18236777
[TBL] [Abstract][Full Text] [Related]
20. Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.
Raman B; Sharma BA; Butala R; Ghugare PD; Kumar A
J Pharm Biomed Anal; 2010 May; 52(1):73-8. PubMed ID: 20079995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
